Was Alois Alzheimer Right or Wrong?

Why senile dementia was misclassified as "Alzheimer's disease," and how it confused the field.

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

In 1907, Aloysius "Alois" Alzheimer presented a rare case of dementia in a 51-year-old woman. This "presenile dementia" (younger than 60) was thought distinct enough from "senile dementia" (older than 65) to warrant a new name, thus it became known as, "Alzheimer's disease" (AD).

In the 1970s, however, some researchers argued that because of their similar symptoms and diagnostic hallmarks, "Alzheimer disease and senile dementia should be considered a single disease."1 This would mean that Alzheimer was wrong. Since then, AD research has been directed at finding a pathogenic cause, be it genetic, metabolic, toxic, or some other causative factor. But after 30 years, while the cause for presenile dementia, or early-onset familial AD, has been essentially found in the form of three mutant genes, the cause for senile dementia, or late-onset sporadic AD, remains unknown.2 Perhaps Alzheimer was right, after all.

Consider other diseases with onset at both middle ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Ming Chen

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo